Effect of Canagliflozin on sympathetic activity and coronary plaque in DM patients with ACS
Not Applicable
- Conditions
- DM Patients with ACS
- Registration Number
- JPRN-UMIN000025749
- Lead Sponsor
- Dividion of Cardiology, Department of Medicine, Nihon University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 46
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients receiving insulin injection for DM treatment 2.Severe heart failure 3.Advenced CKD(<eGFR30ml/min or HD) 4.Contraindication of Canagliflozin 5.patinets who are ineligible in the opinion of the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method